Findings upheld; limited market access allowed only for preferential equity issuance to specified investors and conditional Rs.50 crore loan.

AT upheld the impugned findings against the appellant but granted a limited carve-out: the appellant may access the securities market solely to issue fresh equity by preferential allotment to a specified prospective investor and group entities, and may accept a proposed Rs.50 crore loan prior to issuance subject to regulatory approvals and compliance with applicable law. SEBI's restraint preventing the restrained individuals from serving as KMP in other companies for one year remains effective, but continuation of one restrained individual as a director of the appellant was permitted. All other directions stand; penalty may be paid within six weeks.

---

---

ISSUES PRESENTED AND CONSIDERED

1. Whether a listed company restrained from accessing the securities market by a regulator can be permitted limited market access to admit fresh equity investment from a prospective foreign investor for revival and protection of public shareholders' interest.

2. Whether an individual restrained from being a Key Managerial Personnel (KMP) in "other Companies" by the regulator may nonetheless continue as a Director of the listed company seeking revival, at least for a transitional period.

3. Whether conditions and safeguards are required and sufficient if limited market access and fresh infusion by the prospective investor are permitted (e.g., undertakings, lock-in, compliance with external commercial borrowing approvals, and preservation of other regulatory directions).

ISSUE-WISE DETAILED ANALYSIS

Issue 1 - Limited market access to allow fresh equity infusion for revival

Legal framework: The regulator's powers to restrain entities from accessing the securities market are exercised to protect investors' interests and promote development of the securities market; such restraints operate subject to applicable securities laws and may be tailored where revival and protection of public shareholders are at stake.

Precedent Treatment: No prior judicial precedent was cited or relied upon in the reasoning of the Tribunal; the Tribunal assessed the matter on merits and regulatory objectives.

Interpretation and reasoning: The Tribunal recognised that the listed company has public shareholding exceeding 99% and is running losses with risk of insolvency absent fresh funds. The regulator does not ordinarily interfere with corporate business decisions or capital-raising strategies so long as securities laws are not violated; however, when directions have been issued, the company must demonstrate why revival should be achieved by modifying those directions and why the proposed mode of capital infusion is appropriate. The prospective investor's proposal lacked detailed documentation before the regulator, and the regulator reasonably questioned the disproportion between claimed company valuation and proposed investment; nonetheless, the Tribunal found that permitting limited access for preferential allotment to a bona fide investor could be in the public shareholders' interest to arrest further losses.

Ratio vs. Obiter: Ratio - The Tribunal upheld the regulator's findings on merits but carved out a limited exception permitting the company to access the securities market solely for preferential allotment of fresh equity to the prospective investor, subject to conditions. Obiter - Observations about the regulator's general non-interventionist stance in ordinary business decisions are explanatory and not determinative of the specific relief.

Conclusions: The regulator's directions are upheld except that the company is permitted to issue fresh equity shares by way of preferential allotment to the prospective investor in accordance with applicable law, subject to specified conditions (affidavit of non-connection, 18-month lock-in, compliance with extant laws). The company remains otherwise restrained from accessing the securities market.

Issue 2 - Continuance on the board of a Director who is restrained from being KMP in other companies

Legal framework: Regulatory directions restrained certain individuals from being KMP in "other Companies" for a period; the operative effect of such restraint on continued directorship in the company under restraint required interpretation.

Precedent Treatment: No precedent was invoked; the Tribunal interpreted the scope of the regulator's restraint as applied in the impugned order.

Interpretation and reasoning: The impugned order restrained the individuals from being KMP in other companies for one year. The Tribunal held that such restraint does not automatically preclude an individual from continuing as a Director of the listed company itself. Given the company's public shareholding and need for management continuity to effect revival, the regulator's objection to the individual's continuance on the board was found to be not tenable in the circumstances of this case.

Ratio vs. Obiter: Ratio - The Tribunal's determination that the specific restraint on being a KMP elsewhere does not bar continuation as a Director of the subject company is decisive for the parties and forms part of the dispositive order. Obiter - Any broader statement about the general scope of KMP restraints across different regulatory contexts not necessary to the decision.

Conclusions: Continuance of the restrained individual as a Director of the company for transitional purposes is permissible; the regulator's objection on this ground is rejected in the present facts.

Issue 3 - Conditions and safeguards for permitting investment and interim financing

Legal framework: Permissible modification of regulatory restraints must be accompanied by safeguards to protect investors and ensure absence of continuing influence or connection with persons found culpable; compliance with external commercial borrowing (ECB) and other statutory requirements is mandatory for debt infusion.

Precedent Treatment: No judicial authority was cited; the Tribunal imposed conditions founded on regulatory objectives and statutory compliance requirements.

Interpretation and reasoning: To mitigate risk of continued influence by previous management and to ensure bona fides of the investor, the Tribunal required an affidavit from the prospective investor declaring no relation or connection with the previous management, to be filed within a specified period. The Tribunal imposed an 18-month lock-in of the fresh equity in accordance with law, and allowed the prospective investor to deposit a specified loan amount prior to equity issuance provided necessary ECB approvals are obtained. The Tribunal emphasized that all other aspects of the regulator's directions remain binding and that any market access is limited to the permitted investment subject to compliance with extant laws.

Ratio vs. Obiter: Ratio - The conditions (affidavit of non-connection, 18-month lock-in, prior loan subject to ECB approvals, and adherence to other directions) are operative terms of the order and constitute the mandatory safeguards enabling the limited exception. Obiter - Discussion of the reasonableness of the prospective investor's motivation, while noted, is ancillary to the imposed conditions.

Conclusions: The Tribunal allowed limited market access for preferential allotment conditional on (a) an affidavit by the prospective investor affirming no connection with the previous management, filed within four weeks; (b) an 18-month statutory lock-in of the fresh equity; (c) permitted prior loan infusion subject to obtaining requisite ECB approvals; and (d) continuing application of all other regulatory restraints except as expressly modified. The company is permitted to pay the penalty within six weeks.

Ancillary findings and disposition

No findings of law were overruled or distinguished from precedent; the Tribunal upheld the impugned order's findings against the company on merits while granting narrowly tailored relief for revival. The Tribunal reserved consideration of separate appeals filed by other noticees and clarified that this order does not prejudice those appeals. Pending interlocutory applications were disposed and no costs were awarded.

---